No Data
Purapharm (01498.HK) recommends reducing its share capital and splitting the unissued shares.
Gelonghui November 1st | Purapharm (01498.HK) announced that the company proposed to implement a reduction and subdivision of its share capital, involving the cancellation of 0.099 US dollars per share of issued common stock in full amount of share capital, reducing the face value of issued common stock from 0.1 US dollars to 0.001 US dollars per share. The statutory but unissued common stock with a face value of 0.1 US dollars per share will be subdivided into 100 shares of new common stock with a face value of 0.001 US dollars per share, and after the reduction and subdivision, the issued common stock with a face value of 0.001 US dollars per share in the company's share capital will become one new common stock, and each share with a face value of 0.
PURAPHARM: Interim Report 2024
Purapharm (01498) fell by 7.90%, now at 0.700 yuan, hitting a 52-week low.
As of 9:30, purapharm (01498) dropped by 7.90% from the previous closing price, now at 0.700 yuan, hitting a 52-week low; the volume is 0.001 million shares, with a turnover of 0.0007 million Hong Kong dollars.
PuraPharm Reports Revenue Growth and Narrowed Losses
Express News | PuraPharm Corp H1 Capex HKD 9.4 Million
Express News | PuraPharm Corp H1 Gross Margin 54.6%
No Data
No Data
